Background Since around 2008, methamphetamine (MA) use has markedly increased in some regions of Germany, including among young women of childbearing age. MA use poses substantial risks to both mother and child. However, pregnancy and parenthood also present unique opportunities to engage affected individuals in treatment, though such opportunities often remain underutilized due to insufficiently targeted interventions. In response, the "mummy think of me" (German: "Mama denk an mich", MAMADAM) program was established in 2016 at the University Hospital Dresden as an interdisciplinary, low-threshold therapeutic offering for pregnant women, mothers, and fathers with methamphetamine use disorder (MUD).Objective This article summarizes current evaluation results of MAMADAM, with the aim of assessing its effectiveness, feasibility, and healthcare policy relevance. Conclusions for program development are drawn, and future research and implementation strategies are outlined.Methods The article describes the conceptual framework and core components of MAMADAM, as well as the methodological approaches employed in its evaluation. The current analyses are based on naturalistic longitudinal observations of the first patient cohorts, which are systematically and comparatively evaluated.Results More than 150 parents with MUD - predominantly young women (mean age similar to 29 years) living in precarious circumstances - have participated in MAMADAM. Over half received addiction-specific treatment for the first time. The primary substance was MA in approximately 65 % of cases. Despite mainly extrinsic motivation (about 70 %) around two-thirds of participants remained in the program. The presence of depressive disorders and untreated ADHD was associated with lower treatment retention.Discussion MAMADAM demonstrates that even highly burdened MA users can be reached and motivated towards abstinence during pregnancy and parenthood through tailored outpatient interventions. Close collaboration with gynecology, pediatrics, child welfare services, and addiction support enables early identification of affected patients and ensures child protection during treatment. Key success factors include the low-threshold, integrative care setting and the utilization of parenthood as a motivational driver. The program addresses a critical care gap and should be both regionally expanded and structurally integrated into routine care.